Pulmonary hypertension in chronic liver disease

被引：119

作者：

Mandell, MS

Groves, BM

机构：

[1] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262

[2] UNIV COLORADO,HLTH SCI CTR,CARDIAC CATHETERIZAT LABS,DENVER,CO 80262

来源：

CLINICS IN CHEST MEDICINE | 1996年 / 17卷 / 01期

关键词：

D O I：

10.1016/S0272-5231(05)70296-3

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Pulmonary hypertension develops in approximately 2% of patients with portal hypertension. Diagnosis is often difficult and requires a high degree of clinical suspicion. Treatment of patients with portal and pulmonary hypertension is limited, and mean survival following diagnosis is approximately 15 months. The effect of liver transplantation on the natural history of disease is discussed.

引用

页码：17 / &

页数：18

共 137 条

[1]

AGGARWAL S, 1987, TRANSPLANT P, V19, P54

[2] PHARMACOTHERAPY OF CHRONIC PULMONARY ARTERIAL-HYPERTENSION - VALUE AND LIMITATIONS .1. PRIMARY PULMONARY-HYPERTENSION [J].